Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| HYPERION DEFI, INC.EYEN · Entity 7220 | VP Research & Development | June 16, 2021 | June 17, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
HYPERION DEFI, INC.
Report date June 16, 2021 · Filed June 17, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $6.01 | Direct | 128,258 |
Reported balance
After 2021-06-16 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2021-06-16 · Grant · Acquired 128,258 · Balance 128,258 F1: 1. This stock option was granted by the Issuer's Board of Directors on January 30, 2021, subject to stockholder approval of an amendment to the Issuer's Amended and Restated 2018 Omnibus Stock Incentive Plan (the "Plan"). The Issuer's stockholders approved the amendment to the Plan on June 16, 2021. One-third of the option becomes exercisable on January 30, 2022 and the remaining shares underlying the option become exercisable in equal increments on each of the 24 one-month anniversaries thereafter. |
Filing footnotes · ownership attribution and instrument terms
F1: 1. This stock option was granted by the Issuer's Board of Directors on January 30, 2021, subject to stockholder approval of an amendment to the Issuer's Amended and Restated 2018 Omnibus Stock Incentive Plan (the "Plan"). The Issuer's stockholders approved the amendment to the Plan on June 16, 2021. One-third of the option becomes exercisable on January 30, 2022 and the remaining shares underlying the option become exercisable in equal increments on each of the 24 one-month anniversaries thereafter.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 16, 2021 Filed Jun 17, 2021 09:20 UTC | HYPERION DEFI, INC. EYEN · Entity 7220 | GrantStock Option (right to buy) · Derivative | 128,258 | $6.01 Strike: $6.01 | $770,830.58 |
DisclosureSEC source: 0001638599-21-000562 · doc4_7272.xml · derivative · entry 1 Clauson Luke · CIK 0001736840 · VP Research & Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 128,258 Underlying: Common Stock · 128,258 shares Expires not disclosed F1 · derivative.expiration_date: 1. This stock option was granted by the Issuer's Board of Directors on January 30, 2021, subject to stockholder approval of an amendment to the Issuer's Amended and Restated 2018 Omnibus Stock Incentive Plan (the "Plan"). The Issuer's stockholders approved the amendment to the Plan on June 16, 2021. One-third of the option becomes exercisable on January 30, 2022 and the remaining shares underlying the option become exercisable in equal increments on each of the 24 one-month anniversaries thereafter. Read SEC document |
| June 30, 2020 Filed Jul 2, 2020 18:07 UTC | HYPERION DEFI, INC. EYEN · Entity 7220 | GrantStock Option (right to buy) · Derivative | 101,358 | $0.00 Strike: $2.72 | $0.00 |
DisclosureSEC source: 0001638599-20-000654 · doc4_6774.xml · derivative · entry 1 Clauson Luke · CIK 0001736840 · VP, R&D and Manufacturing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 101,358 Underlying: Common Stock · 101,358 shares Expires 2030-06-02 F1 · derivative.exercise_date: This stock option was granted by the Issuer's Board of Directors on June 3, 2020, subject to stockholder approval of the Issuer's Amended and Restated 2018 Omnibus Stock Incentive Plan (the "Plan"). The Issuer's stockholders approved the Plan on June 30, 2020. One-third of the option becomes exercisable on June 3, 2021 and the remaining shares underlying the option become exercisable in equal increments on each of the 24 one-month anniversaries thereafter. Read SEC document |
| August 16, 2019 Filed Aug 20, 2019 17:20 UTC | HYPERION DEFI, INC. EYEN · Entity 7220 | GrantStock Option (right to buy) · Derivative | 42,722 | $0.00 Strike: $3.11 | $0.00 |
DisclosureSEC source: 0001638599-19-000790 · doc4_6253.xml · derivative · entry 1 Clauson Luke · CIK 0001736840 · VP, R&D and Manufacturing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,722 Underlying: Common Stock · 42,722 shares Expires 2029-08-16 F1 · derivative.exercise_date: One-third of the option becomes exercisable on August 16, 2020 and the remaining shares underlying the option become exercisable in equal increments on each of the 24 one-month anniversaries thereafter. Read SEC document |
| July 24, 2018 Filed Jul 26, 2018 17:34 UTC | HYPERION DEFI, INC. EYEN · Entity 7220 | GrantStock Option (right to buy) · Derivative | 19,874 | $0.00 Strike: $6.20 | $0.00 |
DisclosureSEC source: 0001638599-18-000812 · doc4_5547.xml · derivative · entry 1 Clauson Luke · CIK 0001736840 · VP, Research and Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,874 Underlying: Common Stock · 19,874 shares Expires 2028-07-24 F1 · derivative.exercise_date: One-third of the option becomes exercisable on July 24, 2019 and the remaining shares underlying the option become exercisable in equal increments on each of the 24-one month anniversaries thereafter. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.